Related Experiment Video
Updated: Feb 21, 2026

Measurements of Physiological Stress Responses in C. Elegans
Published on: May 21, 2020
Epigenetic Control of NRF2-Directed Cellular Antioxidant Status in Dictating Life-Death Decisions
John D Hayes1, Albena T Dinkova-Kostova1
1Jacqui Wood Cancer Centre, Division of Cancer Research, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK.
Abstract:
In this issue of Molecular Cell, Chen et al. (2017) demonstrate that the tumor suppressor protein ARF sensitizes cancer cells to programmed death through a surprising mechanism: ARF physically interacts with and antagonizes activation by acetylation of the master redox regulator NRF2, providing an unusual mode of posttranslational NRF2 regulation.
Insights
The tumor suppressor protein ARF triggers cancer cell death by blocking the master redox regulator NRF2. This study reveals ARF’s novel mechanism of inhibiting NRF2 acetylation and activation.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- The tumor suppressor protein ARF plays a critical role in cancer suppression.
- NRF2 is a master regulator of the cellular redox balance, crucial for cell survival.
- Posttranslational modifications, such as acetylation, are key to regulating protein function.
Purpose of the Study:
- To elucidate the mechanism by which ARF sensitizes cancer cells to programmed cell death.
- To investigate the interaction between ARF and the redox regulator NRF2.
- To understand the role of ARF in the posttranslational regulation of NRF2.
Main Methods:
- Co-immunoprecipitation assays to detect physical interaction between ARF and NRF2.
- Western blotting to assess NRF2 acetylation levels.
- Cell viability assays to measure programmed cell death in cancer cells.
Main Results:
- Chen et al. demonstrate that ARF physically interacts with NRF2.
- ARF antagonizes the acetylation and subsequent activation of NRF2.
- This interaction leads to increased sensitization of cancer cells to programmed death.
Conclusions:
- ARF acts as a tumor suppressor by inhibiting NRF2 activation through a novel mechanism of antagonizing its acetylation.
- This provides an unusual mode of posttranslational NRF2 regulation and a potential therapeutic target in cancer.
More Related Videos
09:02Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
Related Concept Videos
Regulation of the Unfolded Protein Response
Redox Reactions
Circadian Rhythms and Gene Regulation
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Negative Regulator Molecules
Master Transcription Regulators